The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
T Pan, S Kondo, W Le, J Jankovic - Brain, 2008 - academic.oup.com
The ubiquitin-proteasome system (UPS) and autophagy-lysosome pathway (ALP) are the
two most important mechanisms that normally repair or remove abnormal proteins …
two most important mechanisms that normally repair or remove abnormal proteins …
Familial Parkinson's disease–genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease
C Schiesling, N Kieper, K Seidel… - Neuropathology and …, 2008 - Wiley Online Library
The identification of the first gene in familial Parkinson's disease (PD) only 10 years ago was
a major step in the understanding of the molecular mechanisms in neurodegeneration …
a major step in the understanding of the molecular mechanisms in neurodegeneration …
[HTML][HTML] Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy
Parkinson disease (PD) is the most common neurodegenerative movement disorder. An
increase in the amount of α-synuclein protein could constitute a cause of PD. α-Synuclein is …
increase in the amount of α-synuclein protein could constitute a cause of PD. α-Synuclein is …
Exploring gene-environment interactions in Parkinson's disease
CC McCulloch, DM Kay, SA Factor, A Samii, JG Nutt… - Human genetics, 2008 - Springer
The objective of this study was to explore combined effects of four candidate susceptibility
genes and two exposures on Parkinson's disease (PD) risk; namely, α-synuclein (SNCA) …
genes and two exposures on Parkinson's disease (PD) risk; namely, α-synuclein (SNCA) …
Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1
T Kabuta, R Setsuie, T Mitsui… - Human molecular …, 2008 - academic.oup.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of
dopaminergic neurons. The I93M mutation in ubiquitin C-terminal hydrolase L1 (UCH-L1) is …
dopaminergic neurons. The I93M mutation in ubiquitin C-terminal hydrolase L1 (UCH-L1) is …
[HTML][HTML] Deubiquitylating enzymes and disease
S Singhal, MC Taylor, RT Baker - BMC biochemistry, 2008 - Springer
Abstract Abstract Deubiquitylating enzymes (DUBs) can hydrolyze a peptide, amide, ester or
thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally …
thiolester bond at the C-terminus of UBIQ (ubiquitin), including the post-translationally …
Drugs used to treat Parkinson's disease, present status and future directions
OME Abdel-Salam - … (Formerly Current Drug Targets-CNS & …, 2008 - ingentaconnect.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after
Alzheimer's disease. In PD'motor symptoms result from the degeneration and loss of …
Alzheimer's disease. In PD'motor symptoms result from the degeneration and loss of …
Effect of formal statistical significance on the credibility of observational associations
JPA Ioannidis - American journal of epidemiology, 2008 - academic.oup.com
The author evaluated the implications of nominal statistical significance for changing the
credibility of null versus alternative hypotheses across a large number of observational …
credibility of null versus alternative hypotheses across a large number of observational …
The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells
E Kyratzi, M Pavlaki, L Stefanis - Human molecular genetics, 2008 - academic.oup.com
A number of studies have associated the S18Y polymorphic variant of UCH-L1 with
protection from sporadic Parkinson's Disease (PD). The mechanism involved in this …
protection from sporadic Parkinson's Disease (PD). The mechanism involved in this …
α-Synuclein: A therapeutic target for Parkinson's disease?
KA Maguire-Zeiss - Pharmacological research, 2008 - Elsevier
Parkinson's disease is a progressive age-related neurodegenerative disease with invariant
loss of substantia nigra dopamine neurons and striatal projections. This disorder is well …
loss of substantia nigra dopamine neurons and striatal projections. This disorder is well …